1 minute reading time (73 words)

University of Maryland Center of Excellence in Regulatory Science and Innovation Survey Participation Opportunity

The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), in collaboration with the FDA, is conducting research to better understand how compounded products are used in clinical practice. Through completion of each survey, they aim to identify how you use these compounded products in your practice setting. This information will be used by the FDA to inform its development of the 503B Bulks List.

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More